Literature DB >> 23057677

Elevated levels of interleukin 6 and C-reactive protein associated with cognitive impairment in heart failure.

Ponrathi Athilingam1, Jan Moynihan, Leway Chen, Rita D'Aoust, Maureen Groer, Kevin Kip.   

Abstract

There is abundant evidence on inflammatory mechanisms in heart failure (HF) that are used for prognostication of the disease; however, data are lacking regarding the association between elevated cytokines, C-reactive protein (CRP), and cognition in HF. A cross-sectional pilot study of 38 patients with HF, aged 62 years (standard deviation± 9 years), predominantly men (68%) and Caucasian (79%) were screened for cognitive function using the Montreal Cognitive Assessment (MoCA). The study aimed to examine cognitive scores on MoCA with cytokines, interleukin 6 [IL-6] and tumor necrosis factor α [TNF-α], and CRP as indicators of early cognitive changes in HF. The result showed no direct correlation between cardiac variables and the MoCA score. The MoCA score, however, was inversely associated with IL-6 (r=-0.53, P=.001) and CRP (r=-0.34, P=.04), with no association to TNF-α. Regression analysis on the MoCA score and log-transformed IL-6 accounted for an additional 11% variation and remained statistically significant (P=.008) after controlling for covariates of education, living arrangements, and loneliness. The large effect size (R(2) =0.87) found in this pilot study provides rationale for a larger exploratory study to examine associations between cognitive function, cytokines, and CRP levels and help design future intervention studies.
© 2012 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23057677      PMCID: PMC3801169          DOI: 10.1111/chf.12007

Source DB:  PubMed          Journal:  Congest Heart Fail        ISSN: 1527-5299


  50 in total

1.  Effect of high- versus low-dose angiotensin converting enzyme inhibition on cytokine levels in chronic heart failure.

Authors:  L Gullestad; P Aukrust; T Ueland; T Espevik; G Yee; R Vagelos; S S Frøland; M Fowler
Journal:  J Am Coll Cardiol       Date:  1999-12       Impact factor: 24.094

2.  Difficulty taking medications, depression, and health status in heart failure patients.

Authors:  Anne L Morgan; Frederick A Masoudi; Edward P Havranek; Philip G Jones; Pamela N Peterson; Harlan M Krumholz; John A Spertus; John S Rumsfeld
Journal:  J Card Fail       Date:  2006-02       Impact factor: 5.712

Review 3.  The role of oxidative stress in the genesis of heart disease.

Authors:  P K Singal; N Khaper; V Palace; D Kumar
Journal:  Cardiovasc Res       Date:  1998-12       Impact factor: 10.787

Review 4.  Inflammatory and anti-inflammatory cytokines in chronic heart failure: potential therapeutic implications.

Authors:  Pål Aukrust; Lars Gullestad; Thor Ueland; Jan K Damås; Arne Yndestad
Journal:  Ann Med       Date:  2005       Impact factor: 4.709

Review 5.  Evidence for a cytokine model of cognitive function.

Authors:  J McAfoose; B T Baune
Journal:  Neurosci Biobehav Rev       Date:  2008-10-18       Impact factor: 8.989

6.  The 6-minute walk: a new measure of exercise capacity in patients with chronic heart failure.

Authors:  G H Guyatt; M J Sullivan; P J Thompson; E L Fallen; S O Pugsley; D W Taylor; L B Berman
Journal:  Can Med Assoc J       Date:  1985-04-15       Impact factor: 8.262

7.  Cardiac dysfunction and cognition in older adults with heart failure.

Authors:  Karin F Hoth; Athena Poppas; David J Moser; Robert H Paul; Ronald A Cohen
Journal:  Cogn Behav Neurol       Date:  2008-06       Impact factor: 1.600

8.  Effect of angiotensin-converting enzyme inhibitors, beta blockers, statins, and aspirin on C-reactive protein levels in outpatients with heart failure.

Authors:  Karen E Joynt; Wendy A Gattis; Vic Hasselblad; Sergey Y Fuzaylov; Victor L Serebruany; Paul A Gurbel; Laura H Gaulden; G Michael Felker; David J Whellan; Christopher M O'Connor
Journal:  Am J Cardiol       Date:  2004-03-15       Impact factor: 2.778

9.  Inflammatory markers and risk of heart failure in elderly subjects without prior myocardial infarction: the Framingham Heart Study.

Authors:  Ramachandran S Vasan; Lisa M Sullivan; Ronenn Roubenoff; Charles A Dinarello; Tamara Harris; Emelia J Benjamin; Douglas B Sawyer; Daniel Levy; Peter W F Wilson; Ralph B D'Agostino
Journal:  Circulation       Date:  2003-03-25       Impact factor: 29.690

10.  Neuroimaging and correlates of cognitive function among patients with heart failure.

Authors:  Raymond L C Vogels; Joukje M Oosterman; Barbera van Harten; Alida A Gouw; Jutta M Schroeder-Tanka; Philip Scheltens; Wiesje M van der Flier; Henry C Weinstein
Journal:  Dement Geriatr Cogn Disord       Date:  2007-10-15       Impact factor: 2.959

View more
  17 in total

1.  Effects of common chronic medical conditions on psychometric tests used to diagnose minimal hepatic encephalopathy.

Authors:  M M Lauridsen; L Poulsen; C K Rasmussen; M Høgild; M K Nielsen; O B Schaffalitzky de Muckadell; H Vilstrup
Journal:  Metab Brain Dis       Date:  2015-10-05       Impact factor: 3.584

Review 2.  Obesity as a risk factor for poor neurocognitive outcomes in older adults with heart failure.

Authors:  Michael L Alosco; Mary Beth Spitznagel; John Gunstad
Journal:  Heart Fail Rev       Date:  2014-05       Impact factor: 4.214

Review 3.  Cognitive Dysfunction in Heart Failure: Pathophysiology and Implications for Patient Management.

Authors:  Sylvia Ye; Quan Huynh; Elizabeth L Potter
Journal:  Curr Heart Fail Rep       Date:  2022-08-13

4.  An exploratory randomized sub-study of light-to-moderate intensity exercise on cognitive function, depression symptoms and inflammation in older adults with heart failure.

Authors:  Laura S Redwine; Meredith A Pung; Kathleen Wilson; Katherine J Bangen; Lisa Delano-Wood; Barry Hurwitz
Journal:  J Psychosom Res       Date:  2019-11-26       Impact factor: 3.006

5.  Daily Physical Activity Is Associated with Subcortical Brain Volume and Cognition in Heart Failure.

Authors:  Michael L Alosco; Adam M Brickman; Mary Beth Spitznagel; Lawrence H Sweet; Richard Josephson; Erica Y Griffith; Atul Narkhede; Joel Hughes; John Gunstad
Journal:  J Int Neuropsychol Soc       Date:  2015-11       Impact factor: 2.892

Review 6.  Heart Failure and Cognitive Impairment: Clinical Relevance and Therapeutic Considerations.

Authors:  Tuoyo O Mene-Afejuku; Monica Pernia; Uzoma N Ibebuogu; Shobhana Chaudhari; Savi Mushiyev; Ferdinand Visco; Gerald Pekler
Journal:  Curr Cardiol Rev       Date:  2019

7.  Changes in oxidative damage, inflammation and [NAD(H)] with age in cerebrospinal fluid.

Authors:  Jade Guest; Ross Grant; Trevor A Mori; Kevin D Croft
Journal:  PLoS One       Date:  2014-01-14       Impact factor: 3.240

8.  'Hearts and minds': association, causation and implication of cognitive impairment in heart failure.

Authors:  Jane A Cannon; John Jv McMurray; Terry J Quinn
Journal:  Alzheimers Res Ther       Date:  2015-02-27       Impact factor: 6.982

Review 9.  Delirium in heart failure.

Authors:  Michele Correale; Mario Altamura; Raffaella Carnevale; Lucia Tricarico; Stefania Malerba; Anna Maria Gallotta; Claudia Altamura; Michela Perrella; Matteo Di Biase; Antonello Bellomo; Natale Daniele Brunetti
Journal:  Heart Fail Rev       Date:  2020-09       Impact factor: 4.214

Review 10.  Towards Optimal Heart Failure Care: Couples-Oriented Strategies to Improve Patient Adherence and Health Outcomes.

Authors:  Samia R Toukhsati; David L Hare
Journal:  Curr Cardiol Rev       Date:  2016
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.